SESheila Espírito-Santo

Sheila Espírito-Santo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sheila Espírito-Santo has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Ana Carolina de Pádua

    Laboratório de Biologia Celular e Tecidual, Centro de Biociências e Biotecnologia, Universidade Estadual do Norte Fluminense Darcy Ribeiro, Campos dos Goytacazes, Brazil.

    2 shared publications
  • Claudio Alberto Serfaty

    Programa de Neurociências, Departamento de Neurobiologia, Universidade Federal Fluminense, Niterói, Brazil

    2 shared publications
  • Greice Nascimento Pires

    Laboratório de Neurodegeneração e Reparo, Departamento de Patologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

    2 shared publications
  • Henrique Rocha Mendonça

    Instituto de Biodiversidade e Sustentabilidade NUPEM, Universidade Federal do Rio de Janeiro, Macaé, Brazil

    2 shared publications
  • Paula Campello-Costa

    Programa de Pós-Graduação em Neurociências, Departamento de Neurobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, Brazil

    2 shared publications
  • Saulo Augusto Alves da Cruz

    Laboratório de Biologia Celular e Tecidual, Centro de Biociências e Biotecnologia, Universidade Estadual do Norte Fluminense Darcy Ribeiro, Campos dos Goytacazes, Brazil.

    2 shared publications

Latest Publications

  • Open Access

    Letter to the Editor: “VEP Latency Delay Reflects Demyelination Beyond the Optic Nerve in the Cuprizone Model”

    by Henrique Rocha Mendonça, Ana Carolina de Pádua, Saulo Augusto Alves da Cruz, Greice Nascimento Pires, Sheila Espírito-Santo

  • The protective effect of Fingolimod upon visual behavior in a demyelination animal model is associated with synaptopathy prevention

    by Ana Carolina de Pádua, Saulo Augusto Alves da Cruz, Luiza dos Santos Heringer, Greice Nascimento Pires, Daniel Areias da Silva Raquita, Jéssica dos Santos Tavares, Pedro Souto Rodrigues, Ana Beatriz Miranda de Sá, Cintia Monteiro de Barros, Sérgio Henrique Seabra, et al.


  • Open Access

    Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes?

    by Sheila Espírito-Santo, Viníciusgabriel Coutinho, Fláviacarvalho Alcantara Gomes


  • Open Access

    Is There a Connection between the Metabolism of Copper, Sulfur, and Molybdenum in Alzheimer’s Disease? New Insights on Disease Etiology

    by Fábio Cunha Coelho, Giselle Cerchiaro, Sheila Espírito Santo Araújo, João Paulo Lima Daher, Silvia Almeida Cardoso, Gustavo Fialho Coelho, Arthur Giraldi Guimarães

    Alzheimer’s disease (AD) and other forms of dementia was ranked 3rd in both the Americas and Europe in 2019 in a World Health Organization (WHO) publication listing the leading causes of death and disability worldwide. Copper (Cu) imbalance has been reported in AD and increasing evidence suggests metal imbalance, including molybdenum (Mo), as a potential link with AD occurrence.We conducted an extensive literature review of the last 60 years of research on AD and its relationship with Cu, sulfur (S), and Mo at out of range levels.Weanalyzed the interactions among metallic elements’ metabolisms;Cu and Mo are biological antagonists, Mo is a sulfite oxidase and xanthine oxidase co-factor, and their low activities impair S metabolism and reduce uric acid, respectively. We found significant evidence in the literature of a new potential mechanism linking Cu imbalance to Mo and S abnormalities in AD etiology: under certain circumstances, the accumulation of Cu not bound to ceruloplasmin might affect the transport of Mo outside the blood vessels, causing a mild Mo deficiency that might lowerthe activity of Mo and S enzymes essential for neuronal activity. The current review provides an updated discussion of the plausible mechanisms combining Cu, S, and Mo alterations in AD.


  • Astrocytes as a target for Nogo‐A and implications for synapse formation in vitro and in a model of acute demyelination

    by Sheila Espírito‐Santo, Vinícius G Coutinho, Rômulo S Dezonne, Joice Stipursky, Alexandre dos Santos‐Rodrigues, Carolina Batista, Roberto Paes‐De‐Carvalho, Babette Fuss, Flávia Carvalho Alcantara Gomes

    Central nervous system (CNS) function depends on precise synaptogenesis, which is shaped by environmental cues and cellular interactions. Astrocytes are outstanding regulators of synapse development and plasticity through contact‐dependent signals and through the release of pro‐ and antisynaptogenic factors. Conversely, myelin and its associated proteins, including Nogo‐A, affect synapses in a inhibitory fashion and contribute to neural circuitry stabilization. However, the roles of Nogo‐A‐astrocyte interactions and their implications in synapse development and plasticity have not been characterized. Therefore, we aimed to investigate whether Nogo‐A affects the capacity of astrocytes to induce synaptogenesis. Additionally, we assessed whether downregulation of Nogo‐A signaling in an in vivo demyelination model impacts the synaptogenic potential of astrocytes. Our in vitro data show that cortical astrocytes respond to Nogo‐A through RhoA pathway activation, exhibiting stress fiber formation and decreased ramified morphology. This phenotype was associated with reduced levels of GLAST protein and aspartate uptake, decreased mRNA levels of the synaptogenesis‐associated genes Hevin, glypican‐4, TGF‐β1 and BDNF, and decreased and increased protein levels of Hevin and SPARC, respectively. Corroborating these findings, conditioned medium from Nogo‐A‐treated astrocytes suppressed the formation of structurally and functionally mature synapses in cortical neuronal cultures. After cuprizone‐induced acute demyelination, we observed reduced immunostaining for Nogo‐A in the visual cortex accompanied by higher levels of Hevin expression in astrocytes and an increase in excitatory synapse density. Hence, we suggest that interactions between Nogo‐A and astrocytes might represent an important pathway of plasticity regulation and could be a target for therapeutic intervention in demyelinating diseases in the future.


  • Interleukin 4 Leads to Sustained Phosphorylation of the STAT6 and ERK Pathways in the Retina and Disrupts Subcortical Visual Circuitry in Rodents

    by Vanessa Gama Goulart, Grasielle Duarte Menezes, Sheila Espírito-Santo, Adriana da Cunha Faria-Melibeu, Claudio Alberto Serfaty, Paula Campello-Costa

    Objective: Interleukin 4 (IL-4) is an anti-inflammatory cytokine related to different aspects of central nervous system development such as survival, proliferation, and differentiation, among others. Our goals were to investigate the effect of intravitreous treatment with IL-4 on the activation of downstream signaling pathways in the retina and the distribution of retinal axons within the superior colliculus (SC). Material and Methods: Lister hooded rats were submitted to an intravitreous injection of either IL-4 (5 U/µL) or PBS (vehicle) at postnatal day 10 (PND10). At PND11 or PND14, retinas were processed for Western blot or immunohistochemistry. At PND13, a group of animals received an intraocular injection of an anterograde tracer in the left (untreated) eye in order to label the uncrossed retinotectal axons. Results: Our data revealed that intravitreous treatment with IL-4 at PND10 leads to a decrease in GFAP content and a sustained increase in the phosphorylation of STAT6 and ERK levels in the retina. IL-4 also increases retinal axonal arbors within the SC, compared to control groups. Conclusions: These data suggest that a single in vivo treatment with IL-4 during the early stages of development modulates signaling pathways in the retina, resulting in altered binocular subcortical visual connectivity.


  • Open Access

    Intravitreous Injection of Interleukin-6 Leads to a Sprouting in the Retinotectal Pathway at Different Stages of Development

    by Grasielle D. Menezes, Vanessa G. Goulart, Sheila Espírito-Santo, Priscilla Oliveira-Silva, Claudio Alberto Serfaty, Paula Campello-Costa

    Objective: The development of retinotectal pathways form precise topographical maps is usually completed by the third postnatal week. Cytokines participate in the development and plasticity of the nervous system. We have previously shown that in vivo treatment with interleukin 2 disrupts the retinocollicular topographical order in early stages of development. Therefore, we decided to study the effect of a single intravitreous injection of IL-6 upon retinotectal circuitry in neonates and juvenile rats. Materials and Methods: Lister Hooded rats received an intravitreous injection of IL-6 (50 ng/ml) or vehicle (PBS) at either postnatal day (PND)10 or PND30 and the ipsilateral retinotectal pathway was evaluated 4 or 8 days later, respectively. Results: Our data showed that, at different stages of development, a single IL-6 intravitreous treatment did not produce an inflammatory response and increased retinal axon innervation throughout the visual layers of the superior colliculus. Conclusions: Taken together, our data provide the first evidence that a single intravitreous injection with IL-6 leads to sprouting in the subcortical visual connections and suggest that small changes in IL-6 levels might be sufficient to impair the correct neuronal circuitry fine-tuning during brain development.